Quintiles designates Comprehensive with Prime Site status

Wednesday, September 26, 2012 09:58 AM

CRO Quintiles has designated Comprehensive Clinical Development, a Miramar, Fla.-based clinical research company, as a Quintiles Prime Site—a distinction that gives Comprehensive an enhanced role in global clinical research and testing of new and more effective medicines.

As a Quintiles Prime Site, Comprehensive has access to new industry-sponsored clinical trials through Quintiles. Comprehensive joins a group of sites across North and South America, Europe, Africa and Asia, and is the first non-academic, non-hospital based organization awarded this status.

"Comprehensive’s dedication to timeliness and quality, combined with their strong patient relationships and delivery quality, will enhance our ability to recruit patients quickly and efficiently to provide greater value for our customers,” said Lindy Jones, senior vice president, integrated site services, Quintiles. “We look forward to a successful relationship with Comprehensive.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs